The Management of Acute Asthma in Children Clinical Guideline is primarily aimed at medical staff working in any of primary care, local, regional, general or tertiary hospitals, however may be utilised or guide the care provided by other clinicians such as nurses. The information is current at the time of publication and provides a minimum standard for the assessment (including investigations) and management of acute asthma; it does not replace or remove clinical judgement or the professional care and duty necessary for each specific case.
Disclaimer
The South Australian Paediatric Clinical Guidelines have been prepared to promote and facilitate standardisation and consistency of practice, using a multidisciplinary approach.
Information in this guideline is current at the time of publication.
SA Health does not accept responsibility for the quality or accuracy of material on websites linked from this site and does not sponsor, approve or endorse materials on such links.
Although the clinical material offered in this guideline provides a minimum standard it does not replace or remove clinical judgement or the professional care and duty necessary for each specific patient case. Where care deviates from that indicated in the guideline contemporaneous documentation with explanation should be provided.
This guideline does not address all the elements of guideline practice and assumes that the individual clinicians are responsible to:
• discuss care with consumers in an environment that is culturally appropriate and which enables respectful confidential discussion. This includes the use of interpreter services where necessary, • advise consumers of their choice and ensure informed consent is obtained, • provide care within scope of practice, meet all legislative requirements and maintain standards of professional conduct and
• document all care in accordance with mandatory and local requirements. 
Important Points
• Children with asthma should have their severity assessed clinically.
• Salbutamol via metered dose inhaler (MDI/puffer) and spacer is the key emergency treatment.
• Corticosteroid therapy should be considered for most exacerbations.
• Long term management should be reviewed during any acute presentation.
Introduction
• Asthma is one of the commonest conditions in childhood. At any point in time 1 in 9 Australian children will have the diagnosis.
• It is one of the commonest causes for presentation to primary care, emergency departments and for admission to hospital.
• The diagnosis of asthma is usually clinical and should be considered in a child with cough, wheeze or difficulty breathing but may be aided by response to bronchodilators and pulmonary function tests.
• Children who present with an acute episode of asthma may also have had recurrent or persistent symptoms for some time. An acute presentation provides an opportunity to review long term management and any problems should be identified and arrangements made for continuing care.
Exclusions
Most children should be managed according to this guideline. The following children may need to be managed differently:
• Patients admitted to ICU with life-threatening asthma.
• Patients under the care of the WCH Respiratory team.
• Patients who have underlying medical conditions which may affect their respiratory status (e.g. other respiratory disease, heart disease, neuromuscular disorders).
• Infants under 1 year of age.
Definitions & Acronyms • Heart rate -compare to age-appropriate normal ranges (see appendix 2). Remember that β 2 -agonists (Salbutamol, Terbutaline, Eformoterol) will increase the heart rate.
Pulse oximetry should be performed if available. A small decrease in oxygen saturations commonly occurs after initial bronchodilator treatment and should be put into the context of the child's clinical condition and response to treatment. Significant hypoxia is an indicator of more severe asthma.
Peak flow has little use in acute asthma and clinical assessment is the best indicator of severity.
Investigations
Generally no investigations are required in assessing acute asthma.
• Chest x-ray -consider in patients presenting with first episode of wheeze, particularly if doubt about diagnosis. Children with known asthma do not require a CXR unless there is a suspicion of pneumothorax or major collapse/consolidation. Some degree of asymmetry of signs is common.
• Blood tests (including blood gases) -not routinely required.
• Nasopharyngeal aspirate for respiratory viruses -may be taken where identifying a viral pathogen may be useful (e.g. illness not classical of asthma) or for cohorting purposes.
Consider other causes of wheeze (eg. bronchiolitis, viral pneumonitis, aspiration, foreign body aspiration, cardiac failure, congenital airway abnormalities). Many viral lower respiratory infections will respond to bronchodilators as well.
Management
Children should be initially assessed and managed as per the table below.
Assessment and management summary
See summary above.
Medication Doses:
Adrenaline (IM) 10microgram/kg (0.01mL/kg adrenaline 1:1 000) (Maximum dose 500microg (0.5 mL)
Aminophylline (IV)
Loading dose of 5mg/kg (maximum 500mg) over at least 60 minutes followed by an infusion of: <12 years -1 mg/kg/hour 12 years to adult -0.5 to 0.7 mg/kg/hour Prednisolone (Oral) 2mg/kg/day (Maximum dose 60mg) for initial dose and 1mg/kg for subsequent doses. Use multiples of 5mg for ease of administration.
Salbutamol (Inhaled)
<6 years -6 puffs (600 microgram) via spacer or 2.5mg nebulised ≥6 years -12 puffs (1200 microgram) via spacer or 5mg nebulised Children under 4 years can use a face mask with a spacer
Salbutamol continuous nebulisation (Inhaled)
5mg nebule then refill as required with 5mg nebules or 4mL of 0.5% nebuliser solution, refilled as required
Salbutamol (IV)
Bolus: 5microgram/kg/min for first hour then consider infusion. • Discharge medications o Salbutamol initially 3-4 hourly with a weaning plan over the next 3-4 days.
o Continue oral Prednisolone to finish 3-5 days (no need for a weaning dose for courses less than 14 days).
• Inhaler device and spacer technique should be checked before discharge.
• Advise parents to seek further medical attention should the child's condition deteriorate or if there is no significant improvement within 48 hours. Parents should be educated on recognising signs of deterioration.
• Advise GP review in 1-2 weeks and, if possible, arrange GP appointment prior to discharge
• In severe asthma, consider specialist referral -see appendix 5.
• Consider preventive treatment if there are frequent acute episodes or interval symptoms between acute episodes (more than one disturbed night per week, difficulty participating in physical activities or bronchodilator use on more than three days per week). See appendix 1.
Admission criteria (this may require transfer to a hospital with paediatric facilities):
• Bronchodilator requirement more frequently than 3 hourly,
• Oxygen requirement,
• Other factors make discharge unsafe (e.g. social issues, lack of understanding, lack of ability to represent if worsens).
Consider admission to HDU/PICU/MedStar Kids retrieval:
• Signs of critical asthma severity,
• requiring continuous nebulisers for >1 hour without improvement,
• requiring Salbutamol more frequently than every 30 minutes after 2 hours,
• hypoxia despite maximal oxygen or raised CO 2.
Inpatient management
Review regularly as dictated by degree of severity.
Weaning Salbutamol:
• Wean by extending time between doses by 30-60 mins aiming for 3 hours or greater between doses.
• A medical review is required if a patient deteriorates or requires more frequent Salbutamol than previously.
Preventive treatment should be commenced if there are interval symptoms between acute episodes (more than one disturbed night per week, difficulty participating in physical activities, or bronchodilator use on more than three days per week). It should be considered if there are frequent acute episodes. See appendix 1.
If commencing preventive treatment emphasise the importance of ongoing review and arrange follow up if none is in place.
Careful attention must be paid to the delivery system chosen. Where using a puffer, spacer devices should be used at all ages. A well-sealing face mask should be used in younger children (usually < 4 years) but children over 4 years should use the mouthpiece on the spacer. Consider Turbuhalers and Accuhalers in older children and adolescents.
All patients admitted with life threatening asthma (severe enough to require ICU admission) should be reviewed by a Paediatric Respiratory Physician.
Education
• All patients & families should have their level of asthma knowledge reviewed and appropriate education given.
• Ensure that the patient's/carer's device technique is correct.
• If parents/carers smoke, ensure they are aware of the importance of a non-smoking environment and offer information on quitting if possible.
• Patients and families should go home with written education material including an action and discharge plan. See appendix 4.
Discharge from hospital
• Patients can be safely discharged if they are stable after 2 consecutive 3 hour periods between Salbutamol doses.
• Discharge medications:
o Salbutamol usually 3-4 hourly with a weaning plan over the next 3-4 days.
o Preventer if required.
• Arrange follow up -GPs can manage the majority of patients with asthma. Follow up within the next 7 to 10 days is suggested and ideally, an appointment should be made prior to leaving the ward.
• Consider specialist referral for patients with severe or difficult to control asthma. See appendix 5.
• Patients with the following should be considered for referral to an asthma educator or a community asthma nurse: • Australian Medicines Handbook -2010
• British National Formulary for Children -2010 Children - -2011 Information for parents 
IV Salbutamol bolus
• Under 2 years -5 microg/kg over 5 minutes.
• Over 2 years -15 microg/kg over 5 minutes (Maximum dose 250 micrograms). Give in a minimum volume of 5ml (can be diluted with 0.9% sodium chloride).
• Repeat dose at 15 minutes if still not improving.
Salbutamol Infusion
Dose 5 -10 microgram/kg/min for 1 hour then reduce to 1 -2 microgram/kg/min Administration Infuse undiluted via a syringe driver.
Standard infusion -50mg Salbutamol in 50mL
Weight (kg) Infusion rate to achieve 1mcg/kg/min • NB 0.06 x weight = rate in mL/hr to achieve rate of 1mcg/kg/min
• Dosage adjustment may be required for patients with renal impairment
• If infusion is running at less than 1mL/hr a chaser should be run simultaneously to prevent line occlusion
Compatible fluids
• Glucose 5%
• Glucose / sodium chloride combinations
• Sodium chloride 0.9%
Cautions
Closely monitor ECG, blood pressure, potassium and blood glucose
